期刊文献+

体外构建携带PDGF-BB和IGF-1缓释微粒的脱细胞人工真皮 被引量:2

An Experimental Study on Reconstruction of Acellular Dermal Matrix Carried PDGF-BB and IGF-1
下载PDF
导出
摘要 目的探讨体外构建携带并持续释放血小板源生长因子(PDGF-BB)和胰岛素样生长因子(IGF-1)的脱细胞人工真皮的可行性。方法体外合成含PDGF-BB和IGF-1生长因子的可降解微球,并与脱细胞人工真皮联结,Elisa方法检测人工真皮中生长因子释放情况;通过携带生长因子的人工真皮与真皮成纤维细胞的共培养,采用细胞计数及WST-8比色法,观察成纤维细胞的增殖速率与细胞活力。结果携带生长因子的人工真皮与真皮成纤维细胞共培养组与对照组细胞倍增时间分别为(2.01±0.38)d和(7.27±1.16)d,共培养组细胞倍增时间明显缩短(P<0.05,n=5);体外培养7d、14d、21d时,共培养组及对照组细胞活力无统计学差异(P>0.05,n=5)。结论本实验成功制备了能持续释放PDGF-BB和IGF-1生长因子并加速体外培养的成纤维细胞增殖的人工真皮,为加速创面修复的研究提供实验依据。 Objective To explore the reconstruction of acellular dermal matrix carried PDGF-BB and IGF-1 in vitro. Also investigate cultured human fibroblast proliferation and collagen production affected by constructed aeelluar dermal matrix. Methods The degraded micro beads with PDGF-BB and IGF-1 were synthe-sized and connected to aeellular dermal matrix. Acelluar dermal matrix was euhured with fibroblast. Fibroblast proliferation rate and cell variability were observed by eell count and WST-8 colorimeter; The release of PDGF-BB and IGF-1 growth factors were measured by ELISA. Results The population doubling time of acellular dermal matrix fibroblast co-culture group and control group was 2.01±0.38 days and 7.27±1.16 days in experimental group and control group respectively. There was significant difference (P〈0.05). But there was no statistically significant difference in cell viability after culture 7, 14, 21 days. Conclusion Acelluar dermal matrix carried PDGF-BB and IGF-1 micro beads can promote the proliferation of fibroblast with continually release of PDGF-BB and IGF-1 growth factors so it is an effective mothod for wound repair.
机构地区 江西省人民医院
出处 《组织工程与重建外科杂志》 2009年第3期128-130,共3页 Journal of Tissue Engineering and Reconstructive Surgery
基金 江西省卫生局课题(20083011)
关键词 脱细胞人工真皮 血小板源生长因子 胰岛素样生长因子 微球 Acellular artificial dermal matrix PDGF-BB IGF-1 Micro bead
  • 相关文献

参考文献3

二级参考文献12

  • 1[1]Thompson JA, Anderson KD, Dipietro JM, et al. Site-directed neovessel formation in vivo[J]. Science, 1988,241(4817):1349.
  • 2[2]Edelman ER, Mathiowitz E, Langer R, et al. Controlled and modulated release of basic fibroblast growth factor [ J ]. Biomaterials,1991,12(7) :619.
  • 3[3]Pean JM, Menei P, Montero-Menei CN, et al. Intraseptal implantation of NGF-releasing microspheres promote the survival of axotomized cholinergic neurons [ J]. Biomaterials, 2000,21 (20): 2097.
  • 4[4]L am XM, Duenas ET, Eaugherty AL, et al. Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes [J]. J Controlled Release, 2000,67(2-3) :281.
  • 5[5]Cao XD, Shoichet MS. Delivering neuroactive molecules from biodegradable microspheres for application in central nervous system disorders [J]. Biomaterials, 1999,20:329.
  • 6[6]Sato T, ChibaT, Yoshinaga K, etal. Improvement ofin vivo stability of alginate-polylysine capsules [J]. Tohoku J Exo Med, 1988,155(3):271.
  • 7I.Gutierro,R.M.Hernandea,M.Igartua,et al.Influence of dose and immunization route on the serum Ig G antibody response to BSA loaded PLGA microspheres[J].Vaccine,2002,20:2181.
  • 8Jefferly H,Davis SS,O'Hagan D T.The Preparation and Characterization of Poly(Lactide-co-glycolide)Microparticles.Ⅱ.The Entrapment of a Model Protein Using a (Water-in-Oil)-in-Water Emulsion Solvent Evaporation Technique[J].Pharmaceutical Research,1993,10:362.
  • 9Smith PK,Krohn RI,Hermanson GT,et al.Measurement of protein using bicinchoninic acid[J].Analytical Biochemistry,1985,150:76.
  • 10黎洪珊,何应,魏树礼.疫苗控释制剂的研究进展[J].中国药学杂志,1999,34(5):291-296. 被引量:14

共引文献24

同被引文献40

  • 1Chen SG, Tzeng YS, Wang CH. Treatment of severe burn with Der-mACELL( ) , an acellular dermal matrix[ J]. Int J Burns Trauma, 2012, 2(2) : 105 - 109.
  • 2Feng X, Tan J, Pan Y, et al. Control of hypertrophic scar from inception by using xenogenic (porcine) acellular dermal matrix (ADM) to cover deep second degree burn [ J ]. Burns, 2006, 32 (3): 293-298.
  • 3Livesey SA, del Campo AA, Nag A, et al. Acellular dermal matrix and method of use thereof for grafting: United States, 8067149B2 [P]. 2011.
  • 4Li H, Fu X, Zhang L, el al. Research of PDGF-BB gel on the wound healing of diabetic rats and its pharmacodynamics[ J]. J Surg Res, 2008, 145(1) : 41 -48.
  • 5Emmerson E, Campbell L, Davies FC, et al. Insulin-like growth factor-1 promotes wound healing in estrogen-deprived mice: new insights into cutaneous IGF-1R/ERalpha cross talk [ J]. J Invest Dermatol, 2012, 132(12) : 2838 -2848.
  • 6Barrientos S, Stojadinovic O, Golinko MS, et al. Growth factors and eytokines in wound healing [ J ]. Wound Repair Regen, 2008, 16 (5): 585 -601.
  • 7Wainwright DJ. Use of an acellular allograft dermal matrix ( Allo- Derm) in the management of full-thickness burns [ J ]. Burns, 1995, 21(4) : 243 -248.
  • 8Mauviel A. Transforming growth stromal to epithelial cross-talk [ J ] factor-beta signaling in skin: J Invest Dermatol, 2009, 129(1):7-9.
  • 9Hong JP, Kim YW, Lee SK, et al. The effect of continuous release of recombinant human epidermal growth factor (rh-EGF) in chitosan film on full thickness excisinnal porcine wounds [ J ]. Ann Plast Surg, 2008, 61(4) : 457 -462.
  • 10Wang HJ, Wan HL, Yang TS, et al. Acceleration of skin graft healing by growth factors [ J ]. Burns, 1996, 22 ( 1 ) : 10 - 14.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部